AGA

23 drugs in development·17 companies·4 clinical trials

Drug Pipeline by Phase

Approved(5)

Drug	Company
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
credelio quattro	Elanco Animal Health Inc (ELAN)
glycopyrrolate	Amneal Pharmaceuticals, Inc. (AMRX)
sivextro	Curative Biotechnology Inc (CUBT)
Welireg	Merck & Co., Inc. (MRK)

Phase 3(3)

Drug	Company
ONC206	Jazz Pharmaceuticals plc (JAZZ)
vdphl01 bid	Veradermics Incorporated (MANE)
vdphl01 qd	Veradermics Incorporated (MANE)

Phase 2(2)

Drug	Company
lxe408	NOVARTIS AG (NVSEF)
lxe408	Novartis AG (NVS)

Phase 1(7)

Drug	Company
alpha-lactalbumin breast cancer vaccine	Anixa Biosciences Inc (ANIX)
an2-502998	AN2 Therapeutics, Inc. (ANTX)
AN2-502998 (formerly AN15368)	AN2 Therapeutics, Inc. (ANTX)
Breast cancer vaccine (α-lactalbumin)	Anixa Biosciences Inc (ANIX)
LUNAR-H5N1	Arcturus Therapeutics Holdings Inc. (ARCT)
monoclonal antibody jst-010	HCW Biologics Inc. (HCWB)
Monoclonal antibody JST-010	Evotec SE (EVO)

Preclinical(4)

Drug	Company
aeol 10150	AEOLUS PHARMACEUTICALS, INC. (AOLS)
Antibody drug conjugate (ADC) candidates	Fulgent Genetics Inc. (FLGT)
gv104	Canton Strategic Holdings, Inc. (CNTN)
Ovarian cancer vaccine (AMHR2-ED)	Anixa Biosciences Inc (ANIX)

Phase 4(2)

Drug	Company
enalapril	Novartis AG (NVS)
sacubitril/valsartan	Novartis AG (NVS)

BioSniper tracks 23 drugs in development for AGA across 17 companies.

There are 4 clinical trials targeting AGA tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.